[{"Assets_0_Q1_USD":1133926000.0,"CommonStockSharesOutstanding_0_Q1_shares":86068086.0,"NetIncomeLoss_1_Q1_USD":-107290000.0,"StockholdersEquity_0_Q1_USD":830901000.0,"Ticker":"ALNY","CIK":"1178670","name":"ALNYLAM PHARMACEUTICALS, INC.","OfficialName":"Alnylam Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"19459816074.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170505"}]